Troy Wadsworth, MD

Troy Wadsworth, MD, is a board-certified medical oncologist who treats a broad spectrum of oncologic and hematologic conditions including anemia and bleeding disorders. He has a special interest in treating lung, myeloma and lymphoma malignancies. He partners with patients by providing the information they need to make well-informed decisions and control the direction of their health care. Outside of work Dr. Wadsworth enjoys spending time with family, traveling and has an affinity for music.

Languages: English

Certification: American Board of Internal Medicine - Medical Oncology

Professional School: Texas Tech University - Health Sciences Center

Residency: Presbyterian Hospital of Dallas

Fellowship: Drexel University - College of Medicine

Medical Groups: MultiCare, MultiCare Medical Associates

Research: Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. J Thorac Oncol. 2020 Jan;15(1):110-119. doi: 10.1016/j.jtho.2019.09.083.